Lea ning F om Cance : Ex ending Cell Viabili y by Telome ase Modula ion
Modade Sola-Ojoa
aLandma k Uni e si y
Depa men o Chemical Enginee ing, Landma k Uni e si y, PMB 1001, Omu-A an, Kwa a S a e,
Nige ia.a
Abs ac
No mal cells age because hei elome es sho en wi h e e y di ision, e en ually eaching a poin
known as he Hay lick limi . Cance cells a oid his a e by keeping elome ase ac i e, gi ing hem
he abili y o di ide inde ini ely. This commen a y asks whe he he same p inciple, i igh ly
con olled, could be u ned owa d use ul ends. Con ol o elome ase in no mal cells migh
p omo e hei longe i y in biop ocesses whe e cul u e s abili y is pa amoun , o in egene a i e
medicine, whe e issues need mo e ime o egene a e. The idea is simple, bu he pa h o wa d
equi es se ious e o o ensu e sa e y and long- e m con ol. In essence, unde s anding cance o
apply i s s a egic hallma ks in ways ha bene i echnology o human heal h and biop oduc ion.
Keywo ds
Cellula Longe i y; Cance Biology; Biop ocessing; Regene a i e Medicine; Telome ase;
1. In oduc ion
The pu sui o cellula longe i y has been well explo ed as cen al o biomedical and biop ocess
enginee ing. Cells die as pa o he na u al p ocess in which hei di ision po en ial is limi ed by
p og essi e elome e sho ening, eaching a poin desc ibed as he Hay lick limi (E os &
Wal o d, 1984). This phenomenon is a na u al sa egua d o uncon olled p oli e a ion, bu i also
limi s he du abili y o cells o he apeu ic and indus ial applica ions. Cance cells, howe e , ha e
pa icula ly mas e ed s a egies o bypass his cons ain , mainly h ough elome ase eac i a ion
(kuma & Se hi, 2023). This esul s in eplica i e immo ali y, one o he canonical hallma ks o
cance (Blagosklonny, 2022).
While ypically conside ed o be a pa hological adap a ion, elome ase ac i a ion in cance cells
may also be iewed as a molecula bluep in o sus ained cell iabili y. F om an enginee ing
pe spec i e, we can ques ion whe he he mechanisms ha sus ain cance cells’ su i al can be
epu posed o ex end he unc ional li espan o no mal cells unde s ic con ol. This pape
explo es elome ase modula ion as a ou e o ex ending cell iabili y. In egene a i e medicine,
cell du abili y cons ain s he scalabili y o s em cell expansion, and in biop ocessing, i can lead
o lowe yields (Lee e al., 2022). In hese cases, con olled elome ase eac i a ion may o e a
pa h owa ds enhanced pe o mance, wi h s ong in eg a ion o sa e y suicide swi ches.
By e aming elome ase as mo e han an oncogenic d i e , we aim o highligh he po en ial ha
c osses cance biology, egene a i e medicine, and bio echnology, su ounding how cance s’
mas e y o elome ase egula ion could ansla e in o sa e and pu pose ul applica ions.
2. Telome ase in Cance
Cance cells abno mally bypass eplica i e limi s as opposed o heal hy soma ic cells. Telome es
a e a epe i i e nucleo ide sequence a ch omosome ends ha sho en wi h each cell di ision. They
e en ually lead o senescence when sho ened o he maximum limi . Malignan cells can bypass
his by he eac i a ion o elome ase o h ough al e na i e mechanisms ha leng hen elome es.
I has been e ealed ha his eac i a ion is caused by p omo e mu a ions in he Telome ase
Re e se T ansc ip ase (TERT) gene and epigene ic emodeling (Liu e al., 2024). These
mechanisms a e well es ablished in cance biology. Wha is mo e ins uc i e o enginee ing,
howe e , is he p inciple hey illus a e. These mechanisms demons a e ha he human body
al eady has he machine y o suppo inde ini e p oli e a ion. The challenge hen poses whe he
his can be well con olled o ou bene i .
3. Ex ending Cell Viabili y
In bio echnology, imp o ed cell iabili y means a be e p ocess. Mammalian cell lines, such as
he Chinese Hams e O a y (CHO) cells and gene ically modi ied human cells, domina e he
p oduc ion o he apeu ic p o eins and an ibodies (Sha ke & Rahman, 2021). As mo e demand o
biologics a ises, scale-up o hese echnologies is needed.
Cu en me hods o imp o e he iabili y o cell cul u es ely on medium op imiza ion, s ess
esponse egula ion, o clone selec ion owa ds mo e esis an clones (Kasemii e e al., 2021).
While hese app oaches ha e essen ially imp o ed pe o mance, hey do no undamen ally al e
he li espan o cells. The pe sis ence o umo cells o unde go coun less di isions sugges s ha
sus ained elome e main enance is plausible. T ansien elome e ac i a ion could se e as a con ol
le e o ex end p oduc ion cycles. Concep ually, elome ase modula ion could be conside ed as a
p ocess a iable simila o empe a u e o nu ien eed a e. Syn he ic biology o e s ou es o
such con ol, including inducible p omo e s, eedback- egula ed gene ci cui s, o molecula suicide
swi ches o ensu e e e sibili y. The po en ial ad an ages a e ex ended ba ch du a ion and
imp o ed consis ency in p oduc quali y.
4. Challenges and E hical Conside a ions
Telome ase ac i a ion is a hallma k o cance . A emp ing o p olong cell li espan by up egula ion
o elome ase poses he isk o malignan ans o ma ion; ca e ully con olled s a egies, such as
issue-speci ic ac i a ion, a e necessa y o de elop.
Ano he poin o challenge is he deli e y sys em o elome ase ac i a ion. In o de o ex end he
li e o cells, he e has o be a sys em o ac i a e o enhance elome ase in he a ge ed cell. Induce s
such as gene ic and chemical ones a e being explo ed, bu ine- uning is necessa y o a oid
a ec ing any o he cells. E en small e o s in how hese sys ems a e deli e ed cold ha e long-
e m consequences, especially in egene a i e medicine, whe e modi ied cells emain in he body.
F om he e hical poin o iew, a emp s o ex end he leng h o human cell li espans delibe a ely
uel mo e ques ions abou aging. I hese echnology ansla e om lab s udies o clinical
applica ions, con e sa ions on equi able access and un o eseen social consequences should
ine i ably ollow.
5. Fu u e Ou look
Se e al pa hways o esea ch in o elome ase modula ion a e wo h close a en ion. Gene
egula ion echnologies combined wi h syn he ic biology a e capable o designing cell ci cui s ha
could ac i a e elome ase unde con olled condi ions, and o e addi ional sa e y laye s such as
suicide swi ches. Indus ially, ex ending use ul li espans is a good app oach o la ge-scale
biop oduc ion, whe e main aining iable cul u es is c i ical, and egene a i e medicine, whe e
issues wi h g ea e eplica i e esilience a e needed. Fu u e s udies can in eg a e molecula ools
wi h sys ems-le el design o de e mine whe e such modula ion will be e ec i e, sa e, and e hically
accep able.
6. Conclusion
Cance shows us wha happens when elome ase is le uncon olled. We ques ion i we epu pose
jus enough o ha s a egy wi hou c ossing in o dange ? Ex ending cell li e could be help ul in
e y p ac ical ways, om keeping cell cul u es iable o longe p oduc ion o suppo ing issues
in epai . The ask ahead is o lea n how o apply his idea wi h es ain so ha he bene i o added
ime does no come a he cos o sa e y.
Re e ences
Blagosklonny, M. V. (2022). Aging, 14(9), 4176–4187. h ps://doi.o g/10.18632/aging.204082
E os, R. B., & Wal o d, R. L. (1984). 9(1), 49–65. h ps://doi.o g/10.1016/0198-8859(84)90006-
5
Kasemii e, A., A ohou, H. T., De Bleye, C., Sac e, P.-Y., Dumon , E., Hube , P., & Ziemons, E.
(2021). Eu opean Jou nal o Pha maceu ics and Biopha maceu ics, 166, 144–154.
h ps://doi.o g/10.1016/j.ejpb.2021.06.004
kuma , N., & Se hi, G. (2023). Cance Le e s, 578, 216459.
h ps://doi.o g/10.1016/j.canle .2023.216459
Lee, B., Jung, S., Hashimu a, Y., Lee, M., Bo ys, B. S., Dang, T., Kallos, M. S., Rod igues, C. A.
V., Sil a, T. P., & Cab al, J. M. S. (2022). Bioenginee ing, 9(3), 92.
h ps://doi.o g/10.3390/bioenginee ing9030092
Liu, M., Zhang, Y., Jian, Y., Gu, L., Zhang, D., Zhou, H., Wang, Y., & Xu, Z.-X. (2024). Cell
Dea h & Disease, 15(1), 90. h ps://doi.o g/10.1038/s41419-024-06454-7
Sha ke , S. M., & Rahman, A. (2021). Cu en D ug Disco e y Technologies, 18(3), 354–364.
h ps://doi.o g/10.2174/1570163817666200312102137
